Stifel Financial
MRTX

Stifel Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Stifel Financial’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,071
Closed -$357K – 3461
2023
Q4 		$357K Sell
6,071
-21,044
-78% -$1.18M ﹤0.01% 2746
2023
Q3 		$1.18M Buy
27,115
+5,182
+24% +$185K ﹤0.01% 1933
2023
Q2 		$792K Buy
21,933
+902
+4% +$37.2K ﹤0.01% 2226
2023
Q1 		$782K Sell
21,031
-4,218
-17% -$190K ﹤0.01% 2228
2022
Q4 		$1.14M Buy
25,249
+12,914
+105% +$836K ﹤0.01% 1897
2022
Q3 		$861K Sell
12,335
-70
-0.6% -$5.18K ﹤0.01% 2073
2022
Q2 		$833K Buy
12,405
+5,983
+93% +$380K ﹤0.01% 2135
2022
Q1 		$528K Buy
+6,422
New +$657K ﹤0.01% 2545
2021
Q4 		– Sell
-1,224
Closed -$217K – 3497
2021
Q3 		$217K Buy
+1,224
New +$197K ﹤0.01% 3092
2021
Q1 		– Sell
-1,111
Closed -$244K – 3309
2020
Q4 		$244K Buy
+1,111
New +$240K ﹤0.01% 2712
2019
Q3 		– Sell
-3,628
Closed -$375K – 2998
2019
Q2 		$375K Buy
+3,628
New +$282K ﹤0.01% 2355
2018
Q4 		– Sell
-5,000
Closed -$236K – 2836
2018
Q3 		$236K Buy
+5,000
New +$278K ﹤0.01% 2488

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Stifel Financial's MRTX Position: Q1 2024 in Review

Stifel Financial sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 6,071 shares — an estimated $357K sold.

Stifel Financial first reported a position in MRTX in Q3 2018 and held it in 12 quarters. The position peaked at $1.18M in Q3 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Stifel Financial reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Stifel Financial sold 6,071 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $357K.
  • Stifel Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Stifel Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $1.18M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Stifel Financial's 13F filing for Q1 2024, filed 14 May 2024.